Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_34d84d92eec9f232ace0dcb0df59c22c |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6851 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6855 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6889 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6879 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3015 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-09 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 |
filingDate |
2012-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61cbb49ff9d32698eafe1e4409bc8ae9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d46a10a2e35a8d8d0acb47edfff0dfb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12d9a4bc68cece3360dc733fb7e06f5a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f298c59de428c4af8530014abc252806 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e2206de1c122e2275a23dab50203ead http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9204d5ed06a01029335c16bd27580e76 |
publicationDate |
2015-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20150003251-A |
titleOfInvention |
Conjugate Of Anti-CDH3(P-Cadherin) Antibody And Drug |
abstract |
It is an object of the present invention to provide an anti-CDH3 antibody-drug conjugate that efficiently kills cancer cells expressing CDH3. According to the present invention, there is provided an immunoconjugate constituted by linking an antibody against CDH3 or a fragment thereof having CDH3 binding ability to a chemotherapeutic agent. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200000171-U |
priorityDate |
2012-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |